- Drugs
- Tuesday, 07 Jan 2020
Harvest Files Suit Against Falcon International, Inc.
Harvest Health & Recreation Inc. (CSE: HARV, OTCQX: HRVSF) ("Harvest"), a vertically integrated cannabis company with one of the largest and deepest footprints in the U.S., announced that yesterday Harvest filed suit against Falcon International, Inc. ("Falcon") requesting termination and rescission of the Merger Agreement ("Transaction") and return of money Harvest paid to Falcon under the Merger Agreement. As detailed in the Complaint, filed in U.S. Federal Court, District of Arizona, Harvest alleges that Falcon has failed to meet its legal obligations in multiple ways, including the failure to provide auditable financial records, which precludes Harvest from moving forward with the Transaction.
While Harvest remains committed to the long-term potential of legal cannabis sales in California, current market conditions make it difficult to operate profitably there today. If the Transaction does not close for any reason, including those enumerated in the Complaint, the company plans to remove the contribution attributable to Falcon from its 2020 pro forma guidance. Harvest expects overall 2020 pro forma profitability would improve without the revenue contribution from Falcon.
Related Industry Updates
Acne Medication Market is expected to reach US$ 11,802.29 million by 2030
Mar 04, 2024
US Pharmaceutical Market is expected to reach US$ 1,285.79 billion by 2030
Jan 12, 2024
Sutro Biopharma Adds Two Exceptional Leaders to Advisory Boards-- Carlos Paya, MD, PhD, and Lainie Martin, MD
May 22, 2020
African Americans Struggle to Join Legal Marijuana Industry
Feb 12, 2020
Takeda’s $1.7B AI Drug Discovery Deal with Iambic Signals Shift
Feb 10, 2026
Europe Drug Delivery Systems Market Growth Prospects, Trends and Forecast up to 2027
Aug 26, 2020
Former Deputy Head of China's Drug Regulator Sentenced to 16 Years in Prison
Nov 15, 2019